Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

BioAro Inc to Host Inaugural Longevity Innovation Forum in Dubai, UAE


News provided by

BioAro Inc.

24 Jan, 2024, 06:53 GMT

Share this article

Share toX

Share this article

Share toX

Canadian Biotechnology Company Brings Together Leading Experts to Discuss Opportunities and Challenges in Healthy Aging and Longevity Medicine

DUBAI, UAE, Jan. 24, 2024 /PRNewswire/ -- BioAro Inc, a Canadian biotechnology company specializing in precision health and longevity medicine, is excited to announce its inaugural Longevity Innovation Forum, to be held at the Ritz Carlton Hotel, Dubai International Financial District, in Dubai, UAE on January 28, 2024, from 10:30am to 12pm.

Continue Reading
This image opens in the lightbox
Dr. Anmol Kapoor MD FRCPC, Founder and CEO of BioAro Inc.
This image opens in the lightbox
BioAro Inc. to host The Longevity Innovation Forum 2024 in Dubai, UAE.
This image opens in the lightbox
BioAro logo

The Longevity Innovation Forum aims to bring together thought leaders, experts, and innovators in the field of healthy aging and longevity medicine to discuss the latest advancements, opportunities, and challenges in this rapidly evolving field. The roundtable will offer a unique platform for collaboration, knowledge sharing, and networking among professionals passionate about extending and improving human life.

Distinguished speakers from diverse backgrounds will join the forum, providing invaluable insights and perspectives on the subject matter. The panel of featured speakers includes:

  • Anmol Kapoor - A leading entrepreneur, investor and clinical cardiologist in the longevity and precision health space, and Founder/CEO of BioAro Inc, Dr. Kapoor brings a wealth of knowledge and experience in driving innovation and commercialization in the biotechnology industry.
  • Mark Tarnopolsky - A world-renowned physician-scientist and expert in exercise physiology, genetics, and neuromuscular disease research, and Founder/CEO of Exerkine Corporation, Dr. Tarnopolsky's pioneering work has revolutionized the understanding of exercise and aging.
  • Constantine Stratakis - An eminent authority on endocrine disorders and genetics, Chief of Clinical Genetics at Human Longevity Inc, and Co-Founder of Healthspan Digital Inc, Dr Stratakis brings a wealth of expertise on precision health, genes, hormones, circadian rhythms, and longevity.
  • Dema Najjar - Established tastemaker, entrepreneur, investor and financier with a deep understanding of today's luxury consumer and the medical spa category, Founder/CEO of D Luxe Lab, a premier cosmetic and wellness clinic in Toronto, Ontario.
  • Yousef Nassar and Shaker Muasher - experienced entrepreneurs and seasoned venture investors, Founders & Managing General Partners of Kayan Ventures, an early stage Venture Fund with a global remit across select sub-sectors of HealthTech & ClimateTech, focusing on deep-tech and scalable solutions in these spaces.
  • Faramarz Farhoodi - Experienced CEO with more than three decades of recognized leadership in business innovation through AI technology, Founder/Chairman of AI Nexus Healthcare, leveraging the power of cognitive artificial intelligence to solve the world's most pressing healthcare challenges, including health span.
  • Osama El Hassan - Digital health evangelist with more than 25 years of experience in both government and non-for-profit organizations. He is the co-founder and chair-person of ZIMAM, which caters for empowering digital health professionals across the MENA region.
  • Meshari Alwashmi - With over a decade of experience as a digital health epidemiologist and serial entrepreneur, he has successfully introduced innovative technologies to traditional medical practice in the MENA region. He is the Founder/CEO of AmplifAI health that uses computer vision and advanced cameras for early disease detection.

The roundtable discussion will be moderated by Fady Hannah-Shmouni, MD DABIM FRCPC, clinical endocrinologist, geneticist, Professor of Medicine at the University of British Columbia, and Founder/CEO of Healthspan Digital Inc, known for his expertise in rare endocrine disorders, hypertension and personalized medicine.

The Longevity Innovation Forum will delve into various topics, including the latest breakthroughs in precision health and longevity medicine, the impact of genetics on healthy aging, and the challenges and opportunities in developing effective interventions for extending human lifespan.

"We are thrilled to host the inaugural Longevity Innovation Forum in Dubai," said Dr. Anmol Kapoor, Founder and CEO of BioAro Inc. "This event will serve as a significant platform for leading experts and visionaries to exchange ideas, collaborate, and shape the future of healthy aging and longevity medicine. We believe that by bringing together the brightest minds in the field, we can accelerate advancements and drive positive change in the pursuit of longer, healthier lives."

Attendance at the Longevity Innovation Forum is by invitation only, with limited spots available for industry professionals, researchers, investors, and stakeholders interested in the field of longevity medicine. For more information and registration details, please visit the official event website at www.BioAro.com

About BioAro Inc:
BioAro Inc. is a Canadian biotechnology company dedicated to precision health and longevity medicine. With a focus on cutting-edge research, innovative technologies, and strategic collaborations, BioAro Inc is committed to advancing the understanding and application of precision medicine for a better and healthier future.

Media Contact: Patrick Kirkwood, pkirkwood@bioaro.com, 403 860 5683  

Photo - https://mma.prnewswire.com/media/2325727/BioAro_Inc__BioAro_Inc_to_Host_Inaugural_Longevity_Innovation_Fo.jpg

Photo - https://mma.prnewswire.com/media/2325728/BioAro_Inc__BioAro_Inc_to_Host_Inaugural_Longevity_Innovation_Fo.jpg

Logo - https://mma.prnewswire.com/media/2325729/BioAro_Inc__BioAro_Inc_to_Host_Inaugural_Longevity_Innovation_Fo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.